EYEG EyeGate Pharmaceuticals, Inc.
$33.73
EyeGate Pharmaceuticals, Inc. (EYEG) Institutional Ownership
What the institutions did with EYEG last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to.
No institutional holdings on record for EYEG.